BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9824161)

  • 21. MafA has strong cell transforming ability but is a weak transactivator.
    Nishizawa M; Kataoka K; Vogt PK
    Oncogene; 2003 Sep; 22(39):7882-90. PubMed ID: 12970735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Domains of the qin protein required for oncogenic transformation.
    Chang HW; Li J; Vogt PK
    Oncogene; 1996 Jul; 13(2):441-4. PubMed ID: 8710385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncogene qin codes for a transcriptional repressor.
    Li J; Chang HW; Lai E; Parker EJ; Vogt PK
    Cancer Res; 1995 Dec; 55(23):5540-4. PubMed ID: 7585630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
    Lausen J; Cho S; Liu S; Werner MH
    J Biol Chem; 2004 Nov; 279(47):49281-8. PubMed ID: 15377655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site.
    Nicol R; Stavnezer E
    J Biol Chem; 1998 Feb; 273(6):3588-97. PubMed ID: 9452486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ski negatively regulates erythroid differentiation through its interaction with GATA1.
    Ueki N; Zhang L; Hayman MJ
    Mol Cell Biol; 2004 Dec; 24(23):10118-25. PubMed ID: 15542823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adf-1 is a nonmodular transcription factor that contains a TAF-binding Myb-like motif.
    Cutler G; Perry KM; Tjian R
    Mol Cell Biol; 1998 Apr; 18(4):2252-61. PubMed ID: 9528796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ski protein family is required for MeCP2-mediated transcriptional repression.
    Kokura K; Kaul SC; Wadhwa R; Nomura T; Khan MM; Shinagawa T; Yasukawa T; Colmenares C; Ishii S
    J Biol Chem; 2001 Sep; 276(36):34115-21. PubMed ID: 11441023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and activities of the ski oncogene.
    Colmenares C; Stavnezer E
    Semin Cancer Biol; 1990 Dec; 1(6):383-7. PubMed ID: 2103510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of ESE-1 subdomains required to initiate mammary epithelial cell transformation via a cytoplasmic mechanism.
    Prescott JD; Poczobutt JM; Tentler JJ; Walker DM; Gutierrez-Hartmann A
    Mol Cancer; 2011 Aug; 10():103. PubMed ID: 21871131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A carboxyl-terminal region of the ski oncoprotein mediates homodimerization as well as heterodimerization with the related protein SnoN.
    Heyman HC; Stavnezer E
    J Biol Chem; 1994 Oct; 269(43):26996-7003. PubMed ID: 7929440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFI.
    Tarapore P; Richmond C; Zheng G; Cohen SB; Kelder B; Kopchick J; Kruse U; Sippel AE; Colmenares C; Stavnezer E
    Nucleic Acids Res; 1997 Oct; 25(19):3895-903. PubMed ID: 9380514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A domain of the even-skipped protein represses transcription by preventing TFIID binding to a promoter: repression by cooperative blocking.
    Austin RJ; Biggin MD
    Mol Cell Biol; 1995 Sep; 15(9):4683-93. PubMed ID: 7651385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-Ski in health and disease.
    Bonnon C; Atanasoski S
    Cell Tissue Res; 2012 Jan; 347(1):51-64. PubMed ID: 21647564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ski and SnoN, potent negative regulators of TGF-beta signaling.
    Deheuninck J; Luo K
    Cell Res; 2009 Jan; 19(1):47-57. PubMed ID: 19114989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion.
    Tokitou F; Nomura T; Khan MM; Kaul SC; Wadhwa R; Yasukawa T; Kohno I; Ishii S
    J Biol Chem; 1999 Feb; 274(8):4485-8. PubMed ID: 9988677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a core functional and structural domain of the v-Ski oncoprotein responsible for both transformation and myogenesis.
    Zheng G; Teumer J; Colmenares C; Richmond C; Stavnezer E
    Oncogene; 1997 Jul; 15(4):459-71. PubMed ID: 9242383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ski interacts with the evolutionarily conserved SNW domain of Skip.
    Prathapam T; Kühne C; Hayman M; Banks L
    Nucleic Acids Res; 2001 Sep; 29(17):3469-76. PubMed ID: 11522815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of the dachshund homology domain of human SKI.
    Wilson JJ; Malakhova M; Zhang R; Joachimiak A; Hegde RS
    Structure; 2004 May; 12(5):785-92. PubMed ID: 15130471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CREB constitutive activation domain interacts with TATA-binding protein-associated factor 110 (TAF110) through specific hydrophobic residues in one of the three subdomains required for both activation and TAF110 binding.
    Felinski EA; Quinn PG
    J Biol Chem; 1999 Apr; 274(17):11672-8. PubMed ID: 10206980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.